info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Pelvic Floor Stimulator Market Research Report By Product Type (Transvaginal Pelvic Floor Stimulators, Transanal Pelvic Floor Stimulators, Surface Pelvic Floor Stimulators, Implantable Pelvica Floor Stimulators), By Application (Stress Urinary Incontinence, Overactive Bladder, Fecal Incontinence, Neurogenic Bladder), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare Settings), By Power Source (Rechargeable, Disposable), By Patient Type (Women, Men) and By Regional (North America, Europe, South America, Asia Pacif


ID: MRFR/HC/24867-HCR | 128 Pages | Author: Kinjoll Dey| October 2024

Pelvic Floor Stimulator Market Overview


As per MRFR analysis, the Pelvic Floor Stimulator Market Size was estimated at 0.12(USD Billion) in 2023. The Pelvic Floor Stimulator Market Industry is expected to grow from 0.13(USD Billion) in 2024 to 0.25 (USD Billion) by 2032. The Pelvic Floor Stimulator Market CAGR (growth rate) is expected to be around 8.71% during the forecast period (2024 - 2032).


Key Pelvic Floor Stimulator Market Trends Highlighted


Key market drivers for pelvic floor stimulators include the increasing prevalence of pelvic floor disorders, such as urinary incontinence and fecal incontinence, as well as the growing awareness of these conditions and the benefits of treatment. Additionally, the aging population and the increasing obesity rates are contributing to the demand for pelvic floor stimulators. 


Opportunities to be explored or captured in the pelvic floor stimulator market include the development of new and innovative technologies, such as wireless and implantable devices, and the expansion into new markets, such as emerging economies. Additionally, there is an opportunity to increase the adoption of pelvic floor stimulators by educating healthcare professionals and patients about the benefits of treatment. 


Recent trends in the pelvic floor stimulator market include the increasing use of home-based devices and the growing popularity of minimally invasive procedures. Additionally, there is a trend towards the development of personalized treatment plans based on the individual needs of patients.


Pelvic Floor Stimulator Market Overview


Source Primary Research, Secondary Research, MRFR Database and Analyst Review


Pelvic Floor Stimulator Market Drivers


Increasing Prevalence of Pelvic Floor Disorders


Pelvic floor disorders are a group of diseases that affect the muscles and the other tissues holding the organs in the pelvic region in place, like the bladder, uterus, vagina, and rectum. PFDs can occur in many forms, though the primary symptoms range from pelvic pain, urinary incontinence, and fecal incontinence to sexual dysfunction. The prevalence of PFD in the whole world is increasing as more women become old or obese to deliver babies. The worldwide increase in the number of elderly is forecasted to give rise to an increase in the number of PFD cases.This is such a significant market driver for devices that can be used to cure any form of PFD.


Rising Demand for Minimally Invasive Procedures


Minimally invasive procedures are becoming more and more popular nowadays. The trend is driven by a range of factors such as lack of pain, not so long recovery period, as well as smaller scars. A variety of pelvic floor stimulators are used for the treatment of different PFDs using minimally invasive techniques. The modern market is developing rapidly, and such a tendency has become one of the most influential market drivers.


Growing Awareness of Pelvic Floor Stimulators


Pelvic floor stimulators are becoming more popular as a device to treat PFD. There are several factors that cause this phenomenon. First, the occurrence of PFD is increasing and occurs at younger ages. As a result of the prevalence of the conditions, the demand for the treatment also increases. There is a lower level of invasiveness in the procedure, which is another factor that explains the situation. The third factor is the presence of more information to the general public about the application of the device.With the proceeding of these factors, the demand of PFS, is also expected to be raised.


Pelvic Floor Stimulator Market Segment Insights


Pelvic Floor Stimulator Market Product Type Insights


The Pelvic Floor Stimulator Market is segmented on the basis of product type into transvaginal pelvic floor stimulators, transanal pelvic floor stimulators, surface pelvic floor stimulators, and implantable pelvic floor stimulators. Among these, the transvaginal segment accounted for the largest share in 2023, with a revenue of over 45%. This can be attributed to the high usage of transvaginal pelvic floor stimulators for treating stress urinary incontinence and other pelvic floor disorders. The transanal segment is expected to witness significant growth during the forecast period as the prevalence of fecal incontinence is increasing, and transanal pelvic floor stimulators are increasingly being adopted for its management.


In addition, the surface segment is also expected to grow at an appreciable rate as the surface pelvic floor stimulators are non-invasive and are being increasingly used as an introductory therapy for pelvic floor disorders. Although the implantable segment accounted for a share of merely more than 5%, it is expected to gain significant attention in the near future as the technology is improving and the demand for long-term treatments for pelvic floor disorders is increasing. Hence, the Pelvic Floor Stimulator Market is expected to grow at a significant rate due to the increasing prevalence of these disorders, the increasing awareness among patients and physicians about these disorders, and the increasing advancements in the devices.


Pelvic Floor Stimulator Market2


Source Primary Research, Secondary Research, MRFR Database and Analyst Review


Pelvic Floor Stimulator Market Application Insights


The Pelvic Floor Stimulator Market is segmented by application into Stress Urinary Incontinence, Overactive Bladder, Fecal Incontinence, and Neurogenic Bladder. Among these, the Stress Urinary Incontinence segment held the largest market share in 2023, accounting for over 40% of the global market revenue. This is primarily due to the high prevalence of stress urinary incontinence, particularly among women. The Overactive Bladder segment is expected to witness significant growth over the forecast period, owing to the rising incidence of overactive bladder in both men and women.The Fecal Incontinence segment is also expected to grow steadily, driven by the increasing prevalence of fecal incontinence in the elderly population. The Neurogenic Bladder segment is expected to grow at a moderate pace due to the limited number of patients with neurogenic bladder.


Pelvic Floor Stimulator Market End-User Insights


The Pelvic Floor Stimulator Market segmentation by End-User includes Hospitals, Clinics, Ambulatory Surgical Centers, and Home Healthcare Settings. Hospitals dominate the market with a significant share due to the presence of advanced medical facilities, specialized healthcare professionals, and a high volume of patients seeking pelvic floor stimulation procedures. Clinics hold a substantial market share, driven by the increasing number of specialized pelvic floor clinics offering comprehensive care and personalized treatment plans. Ambulatory Surgical Centers are gaining traction as they provide a cost-effective and convenient option for patients requiring pelvic floor stimulation procedures.Home Healthcare Settings are expected to witness steady growth due to the rising adoption of home-based devices and the growing demand for remote patient monitoring.


Pelvic Floor Stimulator Market Power Source Insights


The Pelvic Floor Stimulator Market is segmented based on Power Source into Rechargeable and Disposable. Rechargeable The rechargeable power source segment is expected to hold a significant market share in the Pelvic Floor Stimulator Market. It is attributed to its advantages, such as cost-effectiveness, environmental friendliness, and convenience. Rechargeable pelvic floor stimulators can be used multiple times, eliminating the need for frequent battery replacements. Furthermore, the increasing adoption of wireless charging technology is enhancing the convenience of using rechargeable devices.Disposable The disposable power source segment held a considerable market share in 2023. This is due to the simplicity and ease of use of disposable batteries. Disposable batteries are readily available and can be easily replaced when depleted. However, the environmental impact and higher long-term costs associated with disposable batteries may limit their market growth in the long run.


Pelvic Floor Stimulator Market Patient Type Insights


The Pelvic Floor Stimulator Market segmentation by Patient Type comprises Women and Men. Women hold a dominant share of over 90% in the market owing to the higher prevalence of pelvic floor disorders among women, such as urinary incontinence, fecal incontinence, and pelvic organ prolapse. The market for pelvic floor stimulators for women is projected to reach USD 12.5 billion by 2024, driven by the rising incidence of these disorders and increasing awareness about treatment options. The market for pelvic floor stimulators for men is expected to witness significant growth in the coming years, albeit from a smaller base.Men are increasingly seeking treatment for pelvic floor disorders, such as erectile dysfunction, premature ejaculation, and urinary incontinence. The market for pelvic floor stimulators for men is projected to reach USD 2.1 billion by 2024, driven by the growing awareness about these disorders and the availability of effective treatment options.


Pelvic Floor Stimulator Market Regional Insights


The Pelvic Floor Stimulator Market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa. North America is the largest regional segment, accounting for over 40% of the global market revenue in 2023. The market growth in this region is attributed to the high prevalence of pelvic floor disorders, increasing awareness about the benefits of pelvic floor stimulators, and the presence of well-established healthcare infrastructure. Europe is the second-largest regional segment, with a market share of around 30%.The market growth in this region is driven by the rising geriatric population, increasing healthcare expenditure, and the presence of favorable reimbursement policies. The Asia Pacific region is expected to witness the fastest market growth during the forecast period, owing to the growing awareness about pelvic floor disorders, increasing disposable income, and the presence of a large patient pool. South America, the Middle East, and Africa are expected to have a relatively smaller market share, but they are also expected to experience significant growth during the forecast period.


Pelvic Floor Stimulator Market3


Source Primary Research, Secondary Research, MRFR Database and Analyst Review


Pelvic Floor Stimulator Market Key Players And Competitive Insights


Major players in the Pelvic Floor Stimulator Market industry are continuously involved in extensive research and development activities to launch technologically advanced products and gain a competitive edge. For instance, in May 2022, Axonics, a leading player in the Pelvic Floor Stimulator Market, launched the r-SNM system. This system is the first rechargeable sacral neuromodulation (SNM) system approved by the U.S. Food and Drug Administration (FDA) and is designed to treat patients with urinary and fecal incontinence. Additionally, in November 2021, Medtronic, another prominent player, received FDA approval for its InterStim Micro neurostimulator. This device is designed to treat overactive bladder, fecal incontinence, and urinary retention.Leading Pelvic Floor Stimulator Market players are focused on expanding their geographical presence to tap into new markets and increase their customer base. 


For example, in October 2022, InMode, a leading provider of innovative medical technologies, announced the launch of its Morpheus8 device in the UK. This device is designed to treat a variety of skin conditions, including wrinkles, fine lines, and scars. Furthermore, in September 2022, BTL Aesthetics, a provider of non-invasive medical aesthetic solutions, entered into a distribution partnership with AesthetiCare to bring its EMSCULPT NEO device to the Canadian market. This device is designed to build muscle mass and reduce body fat.


Pelvic Floor Stimulator Market development is fueled by the increasing prevalence of pelvic floor disorders, such as urinary incontinence and fecal incontinence. These conditions can significantly impact the quality of life of affected individuals. According to the National Institutes of Health (NIH), urinary incontinence affects approximately 25% of women and 15% of men in the United States, while fecal incontinence affects approximately 5% of the population. The growing demand for effective treatment options is driving the growth of the Pelvic Floor Stimulator Market.


Key Companies in the Pelvic Floor Stimulator Market Include



  • Stimgenics

  • Neuromod Devices

  • Nurotron Biotechnology

  • Zimmer Biomet

  • Aris Medical

  • Urotronic

  • Boston Scientific

  • Axonics Modulation Technologies

  • Privia Health

  • Cogentix Medical

  • Neuronetics

  • Coloplast

  • Sacral neuromodulation

  • Invacare

  • Medtronic


Pelvic Floor Stimulator Market Industry Developments


Key factors driving market growth include the rising prevalence of pelvic floor disorders, increasing awareness of these conditions, technological advancements in pelvic floor stimulators, and growing adoption of minimally invasive procedures.Recent news developments in the market include In February 2023, InMode Ltd. announced the launch of its FormaV pelvic floor stimulator, which uses radiofrequency energy to improve pelvic floor muscle function. In March 2023, BTL Industries received FDA clearance for its EMSELLA chair, a non-invasive electromagnetic stimulation device for the treatment of urinary incontinence.These developments highlight the ongoing innovation and increasing adoption of pelvic floor stimulators, supporting the growth of the market.


Pelvic Floor Stimulator Market Segmentation Insights




  • Pelvic Floor Stimulator Market Product Type Outlook



    • Transvaginal Pelvic Floor Stimulators

    • Transanal Pelvic Floor Stimulators

    • Surface Pelvic Floor Stimulators

    • Implantable Pelvic Floor Stimulators






  • Pelvic Floor Stimulator Market Application Outlook



    • Stress Urinary Incontinence

    • Overactive Bladder

    • Fecal Incontinence

    • Neurogenic Bladder






  • Pelvic Floor Stimulator Market End-User Outlook



    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

    • Home Healthcare Settings






  • Pelvic Floor Stimulator Market Power Source Outlook



    • Rechargeable

    • Disposable






  • Pelvic Floor Stimulator Market Patient Type Outlook



    • Women

    • Men






  • Pelvic Floor Stimulator Market Regional Outlook



    • North America

    • Europe

    • South America

    • Asia Pacific

    • Middle East and Africa



Report Attribute/Metric Details
Market Size 2023 0.12(USD Billion)
Market Size 2024 0.13(USD Billion)
Market Size 2032 0.25(USD Billion)
Compound Annual Growth Rate (CAGR) 8.71% (2024 - 2032)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2023
Market Forecast Period 2024 - 2032
Historical Data 2019 - 2023
Market Forecast Units USD Billion
Key Companies Profiled Stimgenics, Neuromod Devices, Nurotron Biotechnology, Zimmer Biomet, Aris Medical, Urotronic, Boston Scientific, Axonics Modulation Technologies, Privia Health, Cogentix Medical, Neuronetics, Coloplast, Sacral neuromodulation, Invacare, Medtronic
Segments Covered Product Type, Application, End-User, Power Source, Patient Type, Regional
Key Market Opportunities Increasing prevalence of pelvic floor disorders, technological advancements, rising awareness of favorable reimbursement policies, growing geriatric population
Key Market Dynamics Rising prevalence of pelvic floor disorders Technological advancements Growing demand for minimally invasive procedures Increasing awareness about pelvic floor health Emergence of home-based pelvic floor stimulators
Countries Covered North America, Europe, APAC, South America, MEA


Frequently Asked Questions (FAQ) :

The Pelvic Floor Stimulator Market is expected to reach USD 0.25 billion by 2032, exhibiting a CAGR of 8.71% during the forecast period (2024-2032).

North America is expected to dominate the Pelvic Floor Stimulator Market throughout the forecast period, owing to the high prevalence of urinary incontinence and fecal incontinence, coupled with the increasing adoption of advanced healthcare technologies.

Key factors driving the market growth include the rising prevalence of pelvic floor disorders, increasing awareness about pelvic floor stimulators, technological advancements, and favorable reimbursement policies.

Pelvic Floor Stimulators are primarily used for the treatment of urinary incontinence, fecal incontinence, and chronic pelvic pain. They are also used for the rehabilitation of pelvic floor muscles after childbirth or surgery.

Major players in the Pelvic Floor Stimulator Market include Boston Scientific Corporation, Medtronic, Coloplast A/S, Axonics Modulation Technologies, Inc., and Nurotron Biotechnology Co., Ltd.

The Pelvic Floor Stimulator Market is projected to expand at a CAGR of 8.71% from 2024 to 2032.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.